Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01124786 · ClinicalTrials.gov registry record · Phase 2
A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)
A Phase 2 study, sponsored by Clovis Oncology.
- Completed
- Registry status
- Phase 2
- Development phase
- 367
- Enrollment target
NCT01124786: Completed Phase 2 study, sponsored by Clovis Oncology.
NCT01124786 is a Phase 2 study that has completed, run by Clovis Oncology. The registered enrollment target is 367 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (176% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01124786, a Phase 2 study, has completed, sponsored by Clovis Oncology.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 367 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether CO-1.01 is safe and effective in the treatment of patients with metastatic pancreatic cancer and low hENT1 expression compared with gemcitabine.
Interventions
- DRUG Gemcitabine
- DRUG CO-1.01
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 367 participants |
| Start Date | 2010-05 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
What the finished NCT01124786 record still lists
NCT01124786 is an interventional study that assigns participants to a tested intervention. The registered 367 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (176% higher).
The record links to 0 conditions, and to 2 interventions - of which Gemcitabine is the first listed.
NCT01124786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01124786 about?
NCT01124786 is a clinical study titled "A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)". The purpose of this study is to determine whether CO-1.01 is safe and effective in the treatment of patients with metastatic pancreatic cancer and low hENT1 expression compared with gemcitabine.
What is the current status of trial NCT01124786?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 367 participants. The study started on 2010-05. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01124786?
The interventions under investigation include: Gemcitabine (DRUG), CO-1.01 (DRUG).
Who is sponsoring clinical trial NCT01124786?
This trial is sponsored by Clovis Oncology, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01124786's enrollment target sits among peer trials
367 121st of 2000 higher than 1,880 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia